Mylan Laboratories clinical trials

Acquired by Viatris Inc., Nov 16, 2020 · source ↗

The registry lists 1 studies whose lead sponsor is Mylan Laboratories. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 24, 2005.

Before and after it joined Viatris Inc.

First submitted before Mylan Laboratories became part of Viatris Inc.: 1
First submitted after Mylan Laboratories became part of Viatris Inc.: 0
Unclear, or no submission date: 0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

Status

Completed: 1

Phase

Phase 2: 1

Where

United States: 1

Registry sponsor names on this page

Mylan Laboratories1 study

Something wrong with this grouping? Tell us on the Viatris Inc. page.

Studies

Recruiting first, then most recently updated. Showing 1 of 1. All Viatris Inc. studies →

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV DiseaseCompletedNCT00002110Phase 2
Sponsor listed in the registry: Mylan Laboratories · First submitted before Mylan Laboratories became part of Viatris Inc.